Palisade Bio (PALI) Current Leases (2020 - 2025)
Palisade Bio (PALI) posted quarterly Current Leases of $24000.0 for Q2 2025, down 81.54% year-over-year from $130000.0 in Q2 2024, and down 58.62% quarter-over-quarter from $58000.0 in Q1 2025.
Palisade Bio (PALI) Current Leases (2020 - 2025) Analysis & Trends
Palisade Bio (PALI) has reported Current Leases for 6 consecutive years, with $24000.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Current Leases fell 81.54% year-over-year to $24000.0; the TTM figure through Jun 2025 stood at $24000.0 (down 81.54% YoY), while the FY2024 annual figure was $90000.0, down 25.62% from the prior year.
- Current Leases eased to $24000.0 in Q2 2025 per PALI's latest filing, from $58000.0 in the prior quarter.
- Across five years, Current Leases topped out at $184000.0 in Q2 2021 and bottomed at $24000.0 in Q2 2025.
- Historically, Current Leases has averaged $107764.7 across 5 years, with a median of $112000.0 in 2021.
- Annual changes were most pronounced in 2023 — Current Leases surged 67.69% — and 2025, when it sank 81.54%.
- Palisade Bio's Current Leases stood at $112000.0 in 2021, then dropped by 6.25% to $105000.0 in 2022, then increased by 15.24% to $121000.0 in 2023, then slipped by 25.62% to $90000.0 in 2024, then plunged by 73.33% to $24000.0 in 2025.
- Business Quant data shows PALI's Current Leases at $24000.0 in Q2 2025, $58000.0 in Q1 2025, and $90000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Palisade Bio | 372.94 Mn | 247.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 24,000.00 |
| Mar 31, 2025 | 58,000.00 |
| Dec 31, 2024 | 90,000.00 |
| Sep 30, 2024 | 122,000.00 |
| Jun 30, 2024 | 130,000.00 |
| Mar 31, 2024 | 125,000.00 |
| Dec 31, 2023 | 121,000.00 |
| Sep 30, 2023 | 117,000.00 |
| Jun 30, 2023 | 113,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 101,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 65,000.00 |
| Dec 31, 2021 | 112,000.00 |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 184,000.00 |
| Dec 31, 2020 | 168,000.00 |